Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019.

Jeremy Yuen Chun TeohTerry Cheuk-Fung YipGrace Chung-Yan LuiVincent Wai-Sun WongViola Chi-Ying ChowTracy Hang-Yee HoTimothy Chun-Man LiYee-Kit TsePeter Ka-Fung ChiuChi-Fai NgDavid Shu-Cheong HuiHenry Lik-Yuen ChanCheuk-Chun SzetoGrace Lai-Hung Wong

Published in: Journal of the American Society of Nephrology : JASN (2021)

AKI rates were higher among patients with SARS than those with COVID-19. AKI was associated with major adverse clinical outcomes for both diseases. Patients with diabetes mellitus and abnormal liver function were also at risk of developing severe consequences after SARS and COVID-19 infection.

Keyphrases

coronavirus disease
acute kidney injury
respiratory syndrome coronavirus
sars cov
early onset
adverse drug
human health
emergency department
type diabetes
adipose tissue
metabolic syndrome
skeletal muscle
electronic health record